0
Skip to Content
B+ | Fighting Childhood Cancer B+ | Fighting Childhood Cancer
ABOUT
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
GET INVOLVED
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
RESEARCH
RESEARCH
OVERVIEW
RESEARCH GRANTS
NEED HELP?
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
B+ | Fighting Childhood Cancer B+ | Fighting Childhood Cancer
ABOUT
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
GET INVOLVED
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
RESEARCH
RESEARCH
OVERVIEW
RESEARCH GRANTS
NEED HELP?
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
Folder: ABOUT
Folder: GET INVOLVED
Folder: RESEARCH
Folder: NEED HELP?
BLOG
MERCH
DONATE
Back
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
Back
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
Back
RESEARCH
OVERVIEW
RESEARCH GRANTS
Back
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
Epigenetic targeting of radiation resistant medulloblastoma
Northeast, Maryland Julia Travagline 12/14/22 Northeast, Maryland Julia Travagline 12/14/22

Epigenetic targeting of radiation resistant medulloblastoma

Epigenetic targeting of radiation resistant medulloblastoma

Johns Hopkins University, Baltimore, MD

Read More
Enhancement of Oncolytic Virotherapy with Directed Drug Delivery for Pediatric Brain Tumors
South, Alabama Julia Travagline 12/14/22 South, Alabama Julia Travagline 12/14/22

Enhancement of Oncolytic Virotherapy with Directed Drug Delivery for Pediatric Brain Tumors

Enhancement of Oncolytic Virotherapy with Directed Drug Delivery for Pediatric Brain Tumors

MD Anderson Cancer Center, Houston, TX

Read More
Therapeutical reprogramming of DIPG cells
Northeast, New York Julia Travagline 12/14/22 Northeast, New York Julia Travagline 12/14/22

Therapeutical reprogramming of DIPG cells

Therapeutical reprogramming of DIPG cells

Joan & Sanford I. Weill Medical College of Cornell University, New York, NY

Read More
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
West, Colorado Julia Travagline 12/14/22 West, Colorado Julia Travagline 12/14/22

PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy

PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy

University of Colorado Denver, AMC and DC, Aurora, CO

Read More
T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors
Northeast, New York Julia Travagline 12/8/21 Northeast, New York Julia Travagline 12/8/21

T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors

T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors

Memorial Sloan Kettering Cancer Center (MSK), New York, NY

Read More
First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
Midwest, Ohio Julia Travagline 12/8/21 Midwest, Ohio Julia Travagline 12/8/21

First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma

First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma

Case Western Reserve University School of Medicine, Cleveland, OH

Read More
MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition
Northeast, Virginia Julia Travagline 12/8/21 Northeast, Virginia Julia Travagline 12/8/21

MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition

MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition

Virginia Commonwealth University, Richmond, VA

Read More
The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model
New York, Northeast Julia Travagline 12/8/21 New York, Northeast Julia Travagline 12/8/21

The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model

The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model

Albert Einstein College of Medicine, New York, NY

Read More
Exploiting NAD Metabolism Defects in Pediatric Brain Tumors
Northeast, Connecticut Julia Travagline 12/8/21 Northeast, Connecticut Julia Travagline 12/8/21

Exploiting NAD Metabolism Defects in Pediatric Brain Tumors

Exploiting NAD Metabolism Defects in Pediatric Brain Tumors

Yale University, New Haven, CT

Read More
Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma
Utah, West Julia Travagline 8/10/21 Utah, West Julia Travagline 8/10/21

Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma

Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma

University of Utah, Salt Lake City, UT

Read More
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
California, West Julia Travagline 8/10/21 California, West Julia Travagline 8/10/21

Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma

Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma

Beckman Research Institute of the City of Hope, Duarte, CA

Read More
Boosting Immunovirotherapy with Tumor Vaccination to Treat Pediatric Malignant Brain Tumors
Alabama, South Julia Travagline 8/10/21 Alabama, South Julia Travagline 8/10/21

Boosting Immunovirotherapy with Tumor Vaccination to Treat Pediatric Malignant Brain Tumors

Boosting Immunovirotherapy with Tumor Vaccination to Treat Pediatric Malignant Brain Tumors

University of Alabama at Birmingham, Birmingham, AL

Read More
Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid
New Hampshire, Northeast Julia Travagline 8/10/21 New Hampshire, Northeast Julia Travagline 8/10/21

Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid

Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid

Trustees of Dartmouth College, Lebanon, NH

Read More
Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia
California, West Julia Travagline 8/10/21 California, West Julia Travagline 8/10/21

Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia

Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia

Stanford University, Stanford, CA

Read More
Polycomb inhibition sensitizes AML to anthracycline therapy
Ohio, Midwest Julia Travagline 8/10/21 Ohio, Midwest Julia Travagline 8/10/21

Polycomb inhibition sensitizes AML to anthracycline therapy

Polycomb inhibition sensitizes AML to anthracycline therapy

The Research Institute at Nationwide Children’s Hospital, Columbus, OH

Read More
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
New York, Northeast Julia Travagline 8/10/21 New York, Northeast Julia Travagline 8/10/21

Arginine methylation as a potential therapeutic target in high-risk neuroblastoma

Arginine methylation as a potential therapeutic target in high-risk neuroblastoma

University of Rochester, Rochester, NY

Read More
Pediatric Cancer Data Commons
Illinois, Midwest Julia Travagline 8/10/21 Illinois, Midwest Julia Travagline 8/10/21

Pediatric Cancer Data Commons

Pediatric Cancer Data Commons

University of Chicago, Chicago, Illinois

Read More
Artificial Intelligence for Pediatric Cancer
California, West Julia Travagline 8/10/21 California, West Julia Travagline 8/10/21

Artificial Intelligence for Pediatric Cancer

Artificial Intelligence for Pediatric Cancer

Stanford University, Palo Alto, CA

Read More
Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers
Pennsylvania, Northeast Julia Travagline 8/10/21 Pennsylvania, Northeast Julia Travagline 8/10/21

Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers

Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers

Children’s Hospital of Philadelphia, Philadelphia, PA

Read More
Activation of NF-kB in Neuroblastoma Myeloid Cells
Maryland, Northeast Julia Travagline 8/10/21 Maryland, Northeast Julia Travagline 8/10/21

Activation of NF-kB in Neuroblastoma Myeloid Cells

Activation of NF-kB in Neuroblastoma Myeloid Cells

Johns Hopkins University School of Medicine, Baltimore, MD

Read More
Newer Posts
Older Posts

HELPFUL LINKS

BLOG

RESEARCH

SCHOOLS

COMPANIES

FACTS

PRIVACY

ABOUT

B+ EVENTS

B+ HEROES

HERO FUNDS

B+ GEAR

GET ASSISTANCE

 

CONNECT WITH US

Address: The B+ Foundation
101 Rockland Circle
Wilmington, DE 19803

Phone: 302.563.8389 | 845.304.6347
Email: Joe@BePositive.org | Carly@BePositive.org

Family Assistance: Katie@BePositive.org | 609.330.6775

 
Today-logo.png
 
ICRP-logo copy.jpg
 

CONTACT US

Name *
Thank you!

 The Andrew McDonough B+ Foundation is an IRS-certified 501(c)3 organization. Our Tax ID # is 42-1741037.

B+® is a registered trademark